NFKB1 and psoriasis: Additionally, a clear anti-inflammatory effect was observed through the inhibition of the p65 NF-κB signaling cascade induced by LPS/imiquimod and the strong inhibition of the cytokine storm production associated with psoriasis-like skin inflammation, which led to the restoration of normal epidermal structure [23].